Leanna Read
Président chez Carina Biotech Pty Ltd.
Profil
Leanna Read was the founder of TGR BioSciences Pty Ltd.
founded in 2001 where she held the title of Chief Executive Officer & Managing Director until 2010.
Currently, she is the Chairman at Carina Biotech Pty Ltd., a Board of Director at Uniseed Management Pty Ltd., and a Director at Playford Memorial Trust, Inc. since 2014.
Dr. Read's former positions include Non-Executive Director at Kazia Therapeutics Ltd.
and Principal at Flinders University.
Postes actifs de Leanna Read
| Sociétés | Poste | Début |
|---|---|---|
Playford Memorial Trust, Inc.
 Playford Memorial Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous The Playford Memorial Trust, Inc. provides prestigious scholarships and awards for high-achieving South Australians. The company is headquartered in Adelaide, Australia. | Directeur/Membre du Conseil | 01/01/2014 |
Carina Biotech Pty Ltd.
 Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | Président | - |
Uniseed Management Pty Ltd.
 Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Directeur/Membre du Conseil | - |
Anciens postes connus de Leanna Read
| Sociétés | Poste | Fin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 30/01/2007 |
| Flinders University | Corporate Officer/Principal | - |
TGR BioSciences Pty Ltd.
 TGR BioSciences Pty Ltd. Medical DistributorsDistribution Services TGR BioSciences Pty Ltd. engages in the development of drug discovery technologies and products. Its products include captsure technology, Elisa one, surefire, alpha surefire and alpha surefire ultra multiplex. The company was founded by Leanna C. Read in 2001 and is headquartered in Thebarton, SA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Finance |
TGR BioSciences Pty Ltd.
TGR BioSciences Pty Ltd. Medical DistributorsDistribution Services TGR BioSciences Pty Ltd. engages in the development of drug discovery technologies and products. Its products include captsure technology, Elisa one, surefire, alpha surefire and alpha surefire ultra multiplex. The company was founded by Leanna C. Read in 2001 and is headquartered in Thebarton, SA. | Distribution Services |
Playford Memorial Trust, Inc.
Playford Memorial Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous The Playford Memorial Trust, Inc. provides prestigious scholarships and awards for high-achieving South Australians. The company is headquartered in Adelaide, Australia. | Miscellaneous |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | Health Technology |
